Back to Authors

Saad, F

A5132792835 | I4210142730

Mayo Clinic

Centre Hospitalier de l’Université de Montréal

Citations 1

Phase III trial of [177Lu]Lu-PSMA-617 combined with ADT+ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition)

Nuklearmedizin - NuclearMedicine | April 2, 2026 | Volume: 65 | Issue: 02 | Pages: 107-107

10.1055/s-0046-1818191